The long-awaited breakthrough in AIDS treatment is finally here. In mid March, the Food and Drug Administration approved Fuzeon, the first drug in the first new class of anti-HIV medications to be introduced in more than seven years. Fuzeon is like a dream for some 150,000 people—the roughly 30 percent of those on HIV medication who are resistant to existing antiretrovirals and are running out of... More >>>